HMPL-004

DRUG2 trials

Sponsors

Hutchison Medipharma Limited

Conditions

Crohn's DiseaseUlcerative Colitis

Phase 2

Phase II Study of HMPL-004 in Subjects With Crohn's Disease

CompletedNCT00655733

Hutchison Medipharma LimitedCrohn's Disease

Start: 2006-04-30End: 2009-04-30Updated: 2020-01-02

Phase 3

HMPL-004 Maintenance Treatment in Subjects With Mild to Moderate Ulcerative Colitis

TerminatedNCT01882764

Hutchison Medipharma LimitedUlcerative Colitis

Start: 2013-06-30End: 2014-10-31Updated: 2020-01-13